Showing results (311-320 of 600) with videos related to

Sort By:
Pageof 60
Bone|November 1, 1994
Stochastic simulation of vertebral trabecular bone remodelingJ S Thomsen, L Mosekilde, R W Boyce, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|September 19, 2000
Does growth hormone therapy in adult patients with growth hormone deficiency protect against bone loss?K Brixen, T B Hansen, E F Eriksen, et al.
Metabolic Bone Disease & Related Research|January 1, 1984
Reconstruction of the formative site in iliac trabecular bone in 20 normal individuals employing a kinetic model for matrix and mineral appositionE F Eriksen, H J Gundersen, F Melsen, et al.
Circulation|May 7, 1998
Combined hormone replacement therapy does not protect women against the age-related decline in endothelium-dependent vasomotor functionK E Sorensen, I Dorup, A P Hermann, et al.
Acta Radiologica. Oncology|January 1, 1984
Calcium metabolism evaluated by 47Ca kinetics. Methodologic aspects with optimization of a whole-body counterF T Jensen, P Charles, L Mosekilde, et al.
Clinical Science (London, England : 1979)|October 1, 1983
Calcium metabolism evaluated by 47Ca kinetics: estimation of dermal calcium lossP Charles, F T Jensen, L Mosekilde, et al.
Acta Endocrinologica|April 1, 1978
Effect of antithyroid treatment on calcium-phosphorus metabolism in hyperthyroidism. I: Chemical quantities in serum and urineL Mosekilde, M S Christensen, F Melsen, et al.
Acta Medica Scandinavica|January 1, 1980
No effect of cimetidine on calcitonin secretion from medullary thyroid carcinomaK Emmertsen, H E Nielsen, L Mosekilde, et al.
Clinical Physiology (Oxford, England)|April 1, 1983
Calcium metabolism evaluated by 47calcium-kinetics: a physiological model with correction for faecal lag time and estimation of dermal calcium lossF T Jensen, P Charles, L Mosekilde, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|April 22, 2016
Hypercalcemia after discontinuation of long-term denosumab treatmentA S Koldkjær Sølling, T Harsløf, A Kaal, et al.
Pageof 60